Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial | TRIALS |